DR.REDDY'S LABORATORIES LTD. Stock Forecast, DRREDDY stock price prediction. Price target in 14 days: 1237.429 INR. The best long-term & short-term DR.REDDY'S LABORATORIES LTD. share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily DRRED
Dr. Reddy's Laboratories Ltd (RDY) $14.04-0.11(-0.78%) Bid: 14.03 x 1400Ask: 14.04 x 1200 January 24, 2025 1:45 PMESTVolume: 707,081 USDNew York Stock ExchangeDelayed Price Earnings High Target Price 19.40 Mean Target Price 16.87 Low Target Price 14.20 Standard Deviation: 2.60 Number ...
Get real-time updates on Dr. Reddy's Laboratories Ltd Common Stock (RDY) stock quotes, trades, and more. Make informed investments with Nasdaq.
Dr. Reddy’s Laboratories Ltd ADR stock (RDY) in USD 1 RDY = 78.76 USD Mjesec dana 6 mjeseci 1 year 5 godinaDr. Reddy’s Laboratories Ltd ADR stock performance at a glance Check Dr. Reddy’s Laboratories Ltd ADR’s past financial performance, like revenue or net income, plus the top...
in-depth analysis, and powerful stock ratings. create free account bull or bear, seeking alpha is there markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings. create free account rdy dr. reddy's laboratories limited stock price & overview ...
Get the latest insights on Dr. Reddy's Laboratories Ltd Common Stock (RDY) with press releases and corporate news to help you in your trading and investing decisions.
Markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings.Create Free Account RDY Dr. Reddy's Laboratories Limited Earnings Date & History Follow6.05K followers $15.43-0.38 (-2.40...
Dr. Reddy's Laboratories Limited: Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, Stock Dr. Reddy's Laboratories Limited | NSE India S.E.: DRREDDY | NSE India S.E.
复宏汉霖公告,公司于2025年2月6日与Dr. Reddy’s Laboratories SA订立许可协议,授予其在美国及约定的欧洲地区(包括英国、瑞士等42个欧洲国家)开发、生产和商业化HLX15(重组抗CD38全人单克隆抗体注射液)的独家许可。Dr. Reddy’s将向公司支付首付款3300万美元,并基于里程碑达成情况支付不超过9860万美元的里程碑付...
Dr.Reddy’s将拥有HLX15皮下注射和静脉注射两种剂型在美国及42个欧洲国家和地区的独家商业化权益,共计覆盖43个国家和地区。Dr.Reddy’s是一家全球性制药公司,其业务遍布全球逾75个国家和地区 智通财经APP获悉,2025年2月6日,复宏汉霖(02696)宣布与Dr.Reddy’s Laboratories的全资子公司Dr.Reddy’s Laboratories ...